181 related articles for article (PubMed ID: 20486463)
21. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
22. Limited benefit of combined use of tar-based shampoo with 50 microg/ml calcipotriol solution in scalp psoriasis.
Barrett C; Lowson D; Blades KJ;
J Dermatolog Treat; 2005 Aug; 16(3):175. PubMed ID: 16211775
[No Abstract] [Full Text] [Related]
23. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis.
Ashcroft DM; Po AL; Williams HC; Griffiths CE
BMJ; 2000 Apr; 320(7240):963-7. PubMed ID: 10753146
[TBL] [Abstract][Full Text] [Related]
24. Topical psoriasis therapy.
Federman DG; Froelich CW; Kirsner RS
Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
[TBL] [Abstract][Full Text] [Related]
25. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
[No Abstract] [Full Text] [Related]
26. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D and topical therapy.
Lebwohl M
Cutis; 2002 Nov; 70(5 Suppl):5-8. PubMed ID: 12467332
[TBL] [Abstract][Full Text] [Related]
28. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
Abramovits W
J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
[TBL] [Abstract][Full Text] [Related]
29. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
Khandpur S; Sharma VK
Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
[TBL] [Abstract][Full Text] [Related]
30. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
31. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
32. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of a new coal tar preparation in the treatment of chronic plaque-type psoriasis.
Langner A; Wolska H; Fraczykowska M
Br J Clin Pract; 1989 Apr; 43(4):148-50. PubMed ID: 2590625
[TBL] [Abstract][Full Text] [Related]
34. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
35. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
36. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
[TBL] [Abstract][Full Text] [Related]
37. Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl).
Harrington CI
Br J Clin Pract; 1989 Jan; 43(1):27-9. PubMed ID: 2590619
[TBL] [Abstract][Full Text] [Related]
38. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
39. Topical tazarotene vs. coal tar in stable plaque psoriasis.
Kumar U; Kaur I; Dogra S; De D; Kumar B
Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
[TBL] [Abstract][Full Text] [Related]
40. Treatment of psoriasis: role of calcipotriene.
Kirsner RS; Federman D
Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]